I agree, I'd like to see Prurisol partnered first, because the possibilities of Brilacidin are seemingly so huge. But, we have no way of knowing. It's possible that they might partner ONE indication of Bril. I hope not, but I trust Mr. Ehrlich to continue pursuing whatever strategies seem the best.

In an ideal world, getting a big cash infusion for Prurisol and then royalties as it is developed and (hopefully) marketed would be great for the company.